Development Level

Tbio 17 | 11,178
Tdark 8 | 6,569
Tchem 2 | 1,885

Disease

Breast cancer 12 | 3,469
ovarian cancer 11 | 8,297
psoriasis 11 | 6,514
Carcinoma 10 | 11,192
lung cancer 10 | 4,607
invasive ductal carcinoma 9 | 2,867
lung adenocarcinoma 9 | 2,627
ductal carcinoma in situ 8 | 1,686
breast carcinoma 7 | 1,589
Cancer 6 | 2,388
non-small cell lung cancer 6 | 2,799
Multiple myeloma 5 | 1,296
atypical teratoid / rhabdoid tumor 5 | 4,971
cystic fibrosis 5 | 1,629
intraductal papillary-mucinous neoplasm (IPMN) 5 | 3,204
pancreatic cancer 5 | 2,322
Schizophrenia 4 | 1,136
cutaneous lupus erythematosus 4 | 1,016
glioblastoma 4 | 5,635
group 3 medulloblastoma 4 | 4,002
intraductal papillary-mucinous carcinoma (IPMC) 4 | 2,902
malignant mesothelioma 4 | 3,135
non-small cell lung carcinoma 4 | 302
osteosarcoma 4 | 7,766
Breast Neoplasms 3 | 423
Cleft Palate 3 | 265
Connective tissue disease 3 | 59
Lupus erythematosus 3 | 56
Mammary Neoplasms 3 | 403
colon cancer 3 | 1,428
group 4 medulloblastoma 3 | 1,806
medulloblastoma, large-cell 3 | 6,086
pituitary cancer 3 | 1,915
spina bifida 3 | 1,053
Astrocytoma, Pilocytic 2 | 3,006
Disease Models, Animal 2 | 148
Endometriosis 2 | 521
Prostatic Neoplasms 2 | 472
Retinitis pigmentosa 11 2 | 58
Retinitis pigmentosa 20 2 | 5
Thyroiditis 2 | 28
Waldenstrons macroglobulinemia 2 | 742
diabetes mellitus 2 | 1,683
gastric cancer 2 | 445
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,872
lung carcinoma 2 | 2,755
nasopharyngeal carcinoma 2 | 1,024
pancreatic carcinoma 2 | 555
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,911
posterior fossa group A ependymoma 2 | 456
subependymal giant cell astrocytoma 2 | 2,230
Adenocarcinoma of lung 1 | 140
Alzheimer's disease 1 | 640
Ankylosing spondylitis 1 | 134
Arthritis 1 | 276
Atopic dermatitis 1 | 915
Brain Ischemia 1 | 107
Cardiomyopathies 1 | 109
Cocaine-Related Disorders 1 | 90
Depressive disorder 1 | 401
Down syndrome 1 | 480
Esophageal Squamous Cell Carcinoma 1 | 72
Eye disease 1 | 59
Fanconi anemia 1 | 56
Female infertility 1 | 28
Gastric antral vascular ectasia 1 | 10
Gliosis 1 | 56
Heart disease 1 | 288
Hyperalgesia 1 | 80
Infertility, Female 1 | 26
Influenza 1 | 136
Kidney Neoplasm 1 | 28
Kidney Neoplasms 1 | 36
Kidney disease 1 | 411
Lung Neoplasms 1 | 217
Lung disease 1 | 135
Malaria 1 | 155
Male infertility 1 | 199
Mental Depression 1 | 325
Neoplasm Invasiveness 1 | 151
Neoplasm Metastasis 1 | 160
Neoplasm Recurrence, Local 1 | 35
Nerve Degeneration 1 | 118
Neurodegenerative disease 1 | 402
Nijmegen breakage syndrome 1 | 23
Ovarian Neoplasms 1 | 96
Parkinson's disease 1 | 378
Primary ciliary dyskinesia 1 | 75
Squamous cell carcinoma 1 | 125
Squamous cell carcinoma of esophagus 1 | 72
Stomach Neoplasms 1 | 287
Testicular cancer 1 | 25
Toxic encephalopathy 1 | 139
Vaccinia 1 | 32
active ulcerative colitis 1 | 736
adrenocortical carcinoma 1 | 1,385
hepatocellular carcinoma 1 | 536
inflammatory breast cancer 1 | 272
ovarian neoplasm 1 | 93
pediatric high grade glioma 1 | 1,035

Tissue

Endocrine System 27 | 18,159
Blood and immune system 26 | 16,909
Cardiovascular System 26 | 15,192
Digestive Tract 26 | 17,369
Female tissues 26 | 17,400
Liver and Pancreas 26 | 16,750
Male tissues 26 | 17,142
Nervous System 26 | 16,725
Respiratory system 26 | 16,393
Skin and soft tissues 26 | 17,230
Urinary Tract 26 | 16,678

Target Family

Non-IDG 24 | 12,091
Transcription Factor 2 | 1,400
Kinase 1 | 634

Reactome Pathway

RNA Polymerase I Promoter Open... 27 | 27
Signal Transduction 2,657 | 2,657
Immune System 2,101 | 2,101
Metabolism of proteins 2,091 | 2,091
Metabolism 2,081 | 2,081
Post-translational protein mod... 1,398 | 1,398
Gene expression (Transcription... 1,369 | 1,369
RNA Polymerase II Transcriptio... 1,228 | 1,228
Signaling by GPCR 1,217 | 1,217
Innate Immune System 1,176 | 1,176
GPCR downstream signalling 1,157 | 1,157
Generic Transcription Pathway 1,108 | 1,108
Developmental Biology 1,026 | 1,026
Adaptive Immune System 892 | 892
Disease 879 | 879
Cytokine Signaling in Immune s... 752 | 752
Metabolism of lipids 739 | 739
Vesicle-mediated transport 720 | 720
Transport of small molecules 717 | 717
Metabolism of RNA 682 | 682
Hemostasis 666 | 666
Membrane Trafficking 608 | 608
Cell Cycle 590 | 590
G alpha (s) signalling events 574 | 574
Neutrophil degranulation 539 | 539
Axon guidance 533 | 533
Cell Cycle, Mitotic 488 | 488
Cellular responses to external... 463 | 463
GPCR ligand binding 459 | 459
Signaling by Interleukins 448 | 448
Class I MHC mediated antigen p... 435 | 435
Signaling by Receptor Tyrosine... 430 | 430
Olfactory Signaling Pathway 428 | 428
Infectious disease 404 | 404
G alpha (i) signalling events 394 | 394
Cellular responses to stress 386 | 386
Signaling by Rho GTPases 386 | 386
Metabolism of amino acids and ... 370 | 370
Diseases of signal transductio... 367 | 367
Neuronal System 367 | 367
Transcriptional Regulation by ... 365 | 365
M Phase 344 | 344
Class A/1 (Rhodopsin-like rece... 322 | 322
Antigen processing: Ubiquitina... 306 | 306
Extracellular matrix organizat... 297 | 297
Translation 297 | 297
Signaling by WNT 293 | 293
Intracellular signaling by sec... 289 | 289
DNA Repair 288 | 288
Asparagine N-linked glycosylat... 287 | 287
MAPK family signaling cascades 285 | 285
Deubiquitination 276 | 276
Interferon Signaling 275 | 275
Immunoregulatory interactions ... 272 | 272
Metabolism of carbohydrates 271 | 271
Cell Cycle Checkpoints 270 | 270
Organelle biogenesis and maint... 261 | 261
PIP3 activates AKT signaling 259 | 259
RHO GTPase Effectors 257 | 257
Platelet activation, signaling... 256 | 256
HIV Infection 254 | 254
MAPK1/MAPK3 signaling 244 | 244
SLC-mediated transmembrane tra... 243 | 243
Processing of Capped Intron-Co... 238 | 238
RAF/MAP kinase cascade 238 | 238
Chromatin modifying enzymes 236 | 236
Chromatin organization 236 | 236
Neddylation 234 | 234
Transmission across Chemical S... 221 | 221
Biological oxidations 220 | 220
Signaling by ROBO receptors 219 | 219
Keratinization 216 | 216
rRNA processing 216 | 216
G alpha (q) signalling events 211 | 211
Cell surface interactions at t... 210 | 210
Phospholipid metabolism 209 | 209
Fc epsilon receptor (FCERI) si... 204 | 204
Transcriptional regulation by ... 203 | 203
Ub-specific processing proteas... 203 | 203
TCF dependent signaling in res... 199 | 199
Muscle contraction 198 | 198
rRNA processing in the nucleus... 192 | 192
Metabolism of vitamins and cof... 188 | 188
Peptide ligand-binding recepto... 188 | 188
mRNA Splicing 187 | 187
Cilium Assembly 186 | 186
Intra-Golgi and retrograde Gol... 186 | 186
Mitotic G2-G2/M phases 184 | 184
Mitotic Metaphase and Anaphase 183 | 183
G2/M Transition 182 | 182
Major pathway of rRNA processi... 182 | 182
Mitotic Anaphase 182 | 182
Mitotic Prometaphase 181 | 181
Fatty acid metabolism 180 | 180
mRNA Splicing - Major Pathway 179 | 179
Ion channel transport 177 | 177
Signaling by the B Cell Recept... 176 | 176
Regulation of expression of SL... 173 | 173
Programmed Cell Death 172 | 172
Interferon gamma signaling 171 | 171
Separation of Sister Chromatid... 170 | 170

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Histone H2A type 2-A HIST2H2AA3 Tbio Non-IDG -3.04065 999.3 88
Histone H2A type 2-C HIST2H2AC Tbio Non-IDG -3.03938 994.7 101
Histone H2B type 2-E HIST2H2BE Tbio Non-IDG -3.48425 2920.0 135
Histone H2B type 3-B HIST3H2BB Tbio Non-IDG -0.72238 5.02 53
Histone H2A type 1-D HIST1H2AD Tdark Non-IDG 0.17 0.32 11
Histone H2B type 1-K HIST1H2BK Tbio Non-IDG -0.50219 4.04 29
Methyl-CpG-binding domain protein 2 MBD2 Tchem Transcription Factor -1.74971 47.7 297
Histone H2A type 1-J HIST1H2AJ Tdark Non-IDG -0.13212 1.19 16
Histone H2B type 1-M HIST1H2BM Tdark Non-IDG 0.17 0.33 21
Histone H2B type 1-N HIST1H2BN Tbio Non-IDG -1.51422 30.2 60